Osteopontin as a tumor marker in ovarian cancer
Introduction: Ovarian cancer is associated with high morbidity and mortality. This is due to the nonspecific symptoms and no effective screening methods. Currently, carbohydrate antigen-125 (CA125) is used as a tumor biomarker for the diagnosis of ovarian cancer, but it has its own limitations. Henc...
Saved in:
Main Authors: | Shikha Rani (Author), Alka Sehgal (Author), Jasbinder Kaur (Author), Dilpreet Kaur Pandher (Author), Rajpal Singh Punia (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical outcome of abdominal sacrocolpopexy
by: Shikha Rani, et al.
Published: (2015) -
Osteopontin at the Crossroads of Inflammation and Tumor Progression
by: Luigi Mario Castello, et al.
Published: (2017) -
Osteopontin and breast cancer metastasis: Possible role of genistein on the regulation of osteopontin
by: Kitboklang Khongsti, et al.
Published: (2021) -
Role of osteopontin in bone remodeling and orthodontic tooth movement: a review
by: Amarjot Singh, et al.
Published: (2018) -
Exploring the unusual: a testosterone-secreting ovarian tumor
by: Harpreet Kaur, et al.
Published: (2024)